Literature DB >> 12460758

Purification of full-length recombinant human and rat type 1 11beta-hydroxysteroid dehydrogenases with retained oxidoreductase activities.

C Stefan I Nobel1, Finn Dunås, Lars B Abrahmsén.   

Abstract

11beta-Hydroxysteroid dehydrogenase type 1 (11beta-HSD1) is a membrane-bound glycoprotein localized in the endoplasmic reticulum. This enzyme has a key role in regulating local tissue glucocorticoid concentration, acting in vivo predominantly as an oxidoreductase. Previous attempts to purify the native enzyme have yielded a protein without reductase activity. To facilitate detailed studies on its structure and regulation, we have developed a method to purify the full-length human and rat 11beta-HSD1 with retention of their natural oxidoreductase activities. This procedure involved recombinant expression of these histidine-tagged enzymes in the yeast Pichia pastoris; large-scale culturing in a fermentor; and single-step purification by metal affinity chromatography. Both enzymes were 90-95% pure and exhibited dehydrogenase and reductase activities with K(M) values in agreement with those reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460758     DOI: 10.1016/s1046-5928(02)00547-8

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  2 in total

1.  Hexose-6-phosphate dehydrogenase modulates 11beta-hydroxysteroid dehydrogenase type 1-dependent metabolism of 7-keto- and 7beta-hydroxy-neurosteroids.

Authors:  Lyubomir G Nashev; Charlie Chandsawangbhuwana; Zoltan Balazs; Atanas G Atanasov; Bernhard Dick; Felix J Frey; Michael E Baker; Alex Odermatt
Journal:  PLoS One       Date:  2007-06-27       Impact factor: 3.240

2.  Striatal Transcriptome Reveals Differences Between Cognitively Impaired and Unimpaired Aged Male Rats.

Authors:  Volker Korz; Christopher Kremslehner; Jovana Maliković; Ahmed Hussein; Daniel Daba Feyissa; Ionela-Mariana Nagelreiter; Roman Smidak; Roberto Plasenzotti; Florian Gruber; Gert Lubec
Journal:  Front Aging Neurosci       Date:  2021-01-08       Impact factor: 5.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.